Clinical Trial Update: Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether orally disintegrating desmopressin tablets are superior to placebo in reducing night-time voids in adult men with nocturia; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Desmopressin acetate (orally disintegrating tablet) (desmopressin acetate)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED | Results posted: 2015-10-15